Skip to content

Effect Of Ayurveda Drug In Type 2 Diabetes Mellitus

Add On Efficacy Of Nishakatakadi Kashayam Capsule In Type 2 Diabetes Mellitus A Randomized Double Blind Placebo Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098627
Enrollment
70
Registered
2025-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Dr Bhivate Sneha Sanjay
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known subject of Type 2 Diabetes mellitus having HbA1c more than 6.5% with established clinical diagnosis of Type 2 Diabetes mellitus for at least 3 months prior to screening period and are on standard diabetic care Both gender of Age group between 20 to 70 years Subject with a normal serum creatinine level less than 1.5 mg /dl Subject who submits written informed consent

Exclusion criteria

Exclusion criteria: Subjects with Type 1 Diabetes Mellitus. Subjects being treated for Type 2 Diabetes Mellitus with insulin. Subjects with established diagnosis of CAD or any other clinically significant cardiovascular disease. Uncontrolled hypertension. Subjects with established cases of cerebrovascular accidents such as stroke etc. Subjects with any complications of Type 2 Diabetes Mellitus such as retinopathy, neuropathy, nephropathy etc. Pregnant and lactating women. Subjects with evidence of malignancy

Design outcomes

Primary

MeasureTime frame
HbA1c( Glycated hemoglobin A1c)Timepoint: Baseline and 90th Day.

Secondary

MeasureTime frame
FBS(Fasting blood sugar), PPBS(Post prandial blood Sugar), Triglycerides, Triglycerides Glucose Index, Serum CreatinineTimepoint: Baseline and 90th Day.;RBS(Random blood sugar), Urine Sugar, SF-36 QoL(Short Form 36 Quality Of Life), BMI(Body Mass Index) , Weight, Waist Circumference, prameha purva roopa and roopa parametersTimepoint: Baseline, 30th, 60th and 90th Day

Countries

India

Contacts

Public ContactDr Suketha Kumari

KAHERs Shri BMK Ayurveda Mahavidyalaya Post Graduate Studies And Research Centre Shahapur Belagavi

sukethashetty411@gmail.com9483637757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026